Table 3.
Relationship between each baseline variable and arrhythmia recurrence after a single ablation procedure
| Hazard ratio (95% CI) | P-value | |
|---|---|---|
| Age (years) | 1.004 (0.983–1.025) | 0.742 |
| Male gender | 1.048 (0.598–1.838) | 0.869 |
| Hypertension | 1.181 (0.743–1.877) | 0.482 |
| Paroxysmal AF | 0.535 (0.344–0.831) | 0.005 |
| Structural heart disease | 0.931 (0.501–1.729) | 0.821 |
| AF duration (months) | 1.00 (0.997–1.003) | 0.940 |
| LAD (mm) | 1.057 (1.013–1.104) | 0.011 |
| LVEDD (mm) | 1.014 (0.962–1.069) | 0.609 |
| LVESD (mm) | 1.036 (0.997–1.077) | 0.070 |
| LVEF (%) | 0.974 (0.953–0.996) | 0.020 |
| Sport practice | 0.821 (0.475–1.419) | 0.479 |
AF, atrial fibrillation; LAD, left atrial anteroposterior diameter; LVEDD, left ventricle end-diastolic diameter; LVESD, left ventricle end-systolic diameter; LVEF, left ventricle ejection fraction.